Add like
Add dislike
Add to saved papers

Enhancing Nitrogen Reduction Reaction through Formation of 2 D /2D Hybrid Heterostructures of MoS 2 @rGO.

Given the challenging task of constructing an efficient nitrogen reduction reaction (NRR) electrocatalyst with enhanced ambient condition performance, properties such as high specific surface area, fast electron transfer, and design of the catalyst surface constitute a group of key factors to be taken into consideration to guarantee outstanding catalytic performance and durability. Thereof, this work investigates the contribution of the 2D/2D heterojunction interface between MoS2 and reduced graphene oxide (rGO) on the electrocatalytic synthesis of NH3 in an alkaline media. The results revealed remarkable NRR performance on the MoS2 @rGO 2 D /2D hybrid electrocatalyst, characterized by a high NRR sensitivity (faradaic efficiency) of 34.7% with an NH3 yield rate of 3.98 ± 0.19 mg h-1 cm-2 at an overpotential of -0.3 V vs RHE in 0.1 M KOH solution. The hybrid electrocatalysts also exhibited selectivity for NH3 synthesis against the production of the hydrazine (N2 H4 ) byproduct, hindrance of the competitive hydrogen evolution reaction (HER), and good durability over an operation period of 8 h. In hindsight, the study presented a low-cost and highly efficient catalyst design for achieving enhanced ammonia synthesis in alkaline media via the formation of defect-rich ultrathin MoS2 @rGO nanostructures, consisting predominantly of an HER-hindering hexagonal 2H-MoS2 phase.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app